Tucker Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,410
Closed -$326K 812
2025
Q4
$326K Buy
6,410
+1,277
+25% +$65.3K 0.1% 60
2025
Q3
$285K Sell
5,133
-3,563
-41% -$209K 0.09% 77
2025
Q2
$600K Buy
8,696
+4,767
+121% +$324K 0.19% 32
2025
Q1
$273K Sell
3,929
-573
-13% -$47.3K 0.09% 58
2024
Q4
$387K Sell
4,502
-136
-3% -$14.7K 0.04% 72
2024
Q3
$552K Sell
4,638
-1,156
-20% -$154K 0.13% 47
2024
Q2
$827K Buy
5,794
+2,299
+66% +$305K 0.18% 36
2024
Q1
$449K Buy
3,495
+628
+22% +$74.8K 0.1% 68
2023
Q4
$297K Sell
2,867
-190
-6% -$18.8K 0.07% 105
2023
Q3
$278K Buy
3,057
+231
+8% +$20.3K 0.07% 105
2023
Q2
$229K Sell
2,826
-22
-0.8% -$1.8K 0.07% 95
2023
Q1
$227K Sell
2,848
-162
-5% -$11.5K 0.07% 75
2022
Q4
$203K Buy
3,010
+786
+35% +$46.1K 0.07% 52
2022
Q3
$121K Buy
2,224
+710
+47% +$38K 0.04% 70
2022
Q2
$84.4K Sell
1,514
-18
-1% -$999 0.03% 58
2022
Q1
$85.1K Buy
1,532
+180
+13% +$9.24K 0.03% 58
2021
Q4
$75.3K Buy
1,352
+90
+7% +$4.88K 0.02% 65
2021
Q3
$69.5K Buy
1,262
+20
+2% +$967 0.03% 61
2021
Q2
$52K Buy
1,242
+178
+17% +$6.9K 0.02% 69
2021
Q1
$35.9K Buy
1,064
+514
+93% +$18.3K 0.02% 93
2020
Q4
$19.2K Buy
+550
New +$19K 0.01% 149

Other funds holding NVO

Tucker Asset Management's NVO Position: Q1 2026 in Review

Tucker Asset Management sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 6,410 shares — an estimated $326K sold.

Tucker Asset Management first reported a position in NVO in Q4 2020 and held it in 21 quarters. The position peaked at $827K in Q2 2024. 1,278 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Tucker Asset Management reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
  • Tucker Asset Management sold 6,410 Novo Nordisk shares in Q1 2026, an estimated $326K.
  • Tucker Asset Management first reported a position in Novo Nordisk in Q4 2020 and held it in 21 quarters.
  • Tucker Asset Management's Novo Nordisk position peaked at $827K in Q2 2024.
  • 1,278 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Tucker Asset Management's 13F filing for Q1 2026, filed 27 Aug 2026.